SKINVIVE

Allergan Holdings France SAS

Application Filed: 2021-08-19
Trademark Application Details
Trademark Logo SKINVIVE

Mark For: SKINVIVE™ trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles. [all]

Status

2023-05-12 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number90891073
Mark Literal ElementsSKINVIVE
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2022-05-31
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameMatthew O. Brady

Timeline

2021-08-19Application Filed
2021-08-23Location: NEW APPLICATION PROCESSING
2021-08-23Status: Live/Pending
2021-08-23Transaction Date
2022-04-05Published
2022-05-31Location: INTENT TO USE SECTION
2022-11-30Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Allergan Holdings France SAS
AddressTour CBX, 1 passerelle des Reflets Courbevoie FRANCE 92400
Legal Entity TypeSociété à Responsabilité Limitée (sarl)
Legal Entity StateFRANCE

Attorney of Record

MATTHEW O. BRADY
ABBVIE
2525 DUPONT DRIVE
IRVINE, CA 92612

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles
IC 010. US 026 039 044. G & S: Apparatus, namely, injection needles and medical syringes for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
Type CodeType
GS0051Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles
GS0051Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; biological dermal implants, namely, visco-supplementation solutions for filling wrinkles

Trademark Filing History

DescriptionDateProceeding Number
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2023-04-10
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2023-04-10
TEAS CHANGE OF CORRESPONDENCE RECEIVED2023-04-10
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2023-04-10
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2022-12-02
TEAS EXTENSION RECEIVED2022-11-30
SOU EXTENSION 1 GRANTED2022-11-3098765
SOU EXTENSION 1 FILED2022-11-3098765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2022-05-31
PUBLISHED FOR OPPOSITION2022-04-05
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2022-04-05
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2022-03-16
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2022-03-016328
EXAMINERS AMENDMENT E-MAILED2022-03-016328
EXAMINERS AMENDMENT -WRITTEN2022-03-0182426
EXAMINER'S AMENDMENT ENTERED2022-03-0188888
ASSIGNED TO EXAMINER2022-03-0182426
APPROVED FOR PUB - PRINCIPAL REGISTER2022-03-01
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2021-10-07
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2021-10-07
NEW APPLICATION ENTERED IN TRAM2021-08-23
NEW APPLICATION ENTERED2021-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed